Therapy and clinical trials.
Duttaroy
Asim K
AK
Department of Nutrition, University of Oslo, PO Box 1046, Blindern, N-316 Oslo, Norway.
D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics; D001161:Arteriosclerosis / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D002318:Cardiovascular Diseases / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood / Q000378:metabolism; D003497:Cyclic N-Oxides / Q000494:pharmacology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000178:diet therapy* / Q000378:metabolism; D004032:Diet; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006801:Humans; D051379:Mice; D029363:Organic Anion Transporters, Sodium-Dependent / Q000037:antagonists & inhibitors; D016032:Randomized Controlled Trials as Topic; D027981:Symporters / Q000037:antagonists & inhibitors; D014326:Tropanes / Q000494:pharmacology
C466800:1-(4-(4-(3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl)phenoxy)butyl)-4-aza-1-azoniabicyclo(2.2.2)octane; D001057:Apolipoproteins E; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D003497:Cyclic N-Oxides; D005231:Fatty Acids, Unsaturated; D029363:Organic Anion Transporters, Sodium-Dependent; D027981:Symporters; D014326:Tropanes; C071908:sodium-bile acid cotransporter